SANO Diagnostics Information

SANO Diagnostics is pioneering a disposable, cost-effective point-of-care diagnostic platform with initial focus on human chronic wounds, such as diabetic foot ulcers and pressure ulcers. Measuring wound protease-related biochemistry to provide clinicians with more information on their patients' current wound status and progression, Sano's lead diagnostic is designed to help personalize treatment, promoting faster healing and significantly reducing treatment costs. The company is also in early stage development of a diagnostic for use in the equine market. Sano has won several awards/recognitions, including 1st place - Harvard Business School Boston Club – 1st place (judged by VC, angel, legal/service professionals), 1st place - Mass Medical Device Development Center (judged by Smith & Nephew, UMass Medical, legal/service professionals), Finalist - Harvard Business School New Venture Competition (judged by HBS alumni), 1st place Venture Forum 5 Minute Pitch, and 2015 Finalist, $50K Gold Award, MassChallenge (judged by investors, serial entrepreneurs, academic and for-profit execs).